ArticleCancers2022

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target.

Malvina Koni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.